APAview

APAview analyzes alternative polyadenylation (APA) features by integrating APA quantification, gene expression, and clinical data to study APA-associated molecular alterations in hematological cancers such as acute promyelocytic leukemia (APL) and acute myeloid leukemia (AML).


Key Features:

  • Comprehensive Data Integration: Supports multimodal inputs including APA quantification results from QAPA/DaPars, gene expression datasets, and clinical information.
  • Statistical Analyses: Performs correlation analysis, survival analysis, and differential analysis among user-defined groups.
  • Customizable Visualizations: Generates customizable visualizations to represent APA metrics and analysis results.
  • Cross-disease Applicability: Applies to hematological cancers and other diseases given user-provided experimental data.

Scientific Applications:

  • APA dysregulation characterization: Characterizes APA changes associated with pathogenesis in APL and AML.
  • Biomarker and target identification: Identifies APA-derived molecular indices that may serve as biomarkers or therapeutic targets.
  • Translational integration: Integrates clinical and molecular APA data for translational research and patient outcome studies.

Methodology:

Implemented in Python3 using the Flask framework for backend operations and the Jinja2 templating engine.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
web application
Programming Languages:
Python
Added:
11/6/2022
Last Updated:
11/24/2024

Operations

Publications

Hu X, Song J, Chyr J, Wan J, Wang X, Du J, Duan J, Zhang H, Zhou X, Wu X. APAview: A web-based platform for alternative polyadenylation analyses in hematological cancers. Frontiers in Genetics. 2022;13. doi:10.3389/fgene.2022.928862. PMID:36035147. PMCID:PMC9411867.